Fibroblast growth factor-5 participates in the progression of hepatic fibrosis

Experimental Animals

Volumn 63, Issue 1, 2014, Pages 85-92

  Hanaka, Hiromi ^a   Hamada, Tsuyoshi ^a   Ito, Masataka ^a   Nakashima, Hiroyuki ^a   Tomita, Kengo ^a   Seki, Shuhji ^a   Kobayashi, Yasushi ^a   Imaki, Junko ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

FGF5; Hepatic fibrosis; NAFLD; NASH; Two hit theory

Indexed keywords

FIBROBLAST GROWTH FACTOR 5;

ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EXON; GENOME; INFLAMMATION; LIVER CELL; LIVER FIBROSIS; LIVER HISTOLOGY; MALE; MORPHOLOGY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; STEATOSIS;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FATTY LIVER; FIBROBLAST GROWTH FACTOR 5; FIBROSIS; HUMANS; LIVER; MALE; MICE; MICE, INBRED ICR;

EID: 84896731796     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.63.85     Document Type: Article

References (24)

1. Afdhal, N.H. 2012. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both? JAMA. 308: 608-616. [Medline] [CrossRef]
2. Allerstorfer, S., Sonvilla, G., Fischer, H., Spiegl-Kreinecker, S., Gauglhofer, C., Setinek, U., Czech, T., Marosi, C., Buchroithner, J., Pichler, J., Silye, R., Mohr, T., Holzmann, K., Grasl-Kraupp, B., Marian, B., Grusch, M., Fischer, J., Micksche, M., and Berger, W. 2008. FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities. Oncogene 27: 4180-4190. [Medline] [CrossRef]
3. Angulo, P., Keach, J.C., Batts, K.P., and Lindor, K.D. 1999. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30: 1356-1362. [Medline] [CrossRef]
4. Bacon, B.R., Farahvash, M.J., Janney, C.G., and Neuschwander-Tetri, B.A. 1994. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107: 1103-1109. [Medline]
5. Bieghs, V., van Gorp, P.J., Walenbergh, S.M., Gijbels, M.J., Verheyen, F., Buurman, W.A., Briles, D.E., Hofker, M.H., Binder, C.J., and Shiri-Sverdlov, R. 2012. Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice. Hepatology 56: 894-903. [Medline] [CrossRef]
6. Caldwell, S.H., Oelsner, D.H., Iezzoni, J.C., Hespenheide, E.E., Battle, E.H., and Driscoll, C.J. 1999. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29: 664-669. [Medline] [CrossRef]
7. Castellano Tortajada, G. 1999. Nonalcoholic steatohepatitis. Gastroenterol. Hepatol. 22:(Suppl 1): 13-19. [Medline]
8. Corey, K.E., Lai, M., Gelrud, L.G., Misdraji, J., Barlow, L.L., Zheng, H., Andersson, K.L., Thiim, M., Pratt, D.S., and Chung, R.T. 2012. Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis. Clin. Gastroenterol. Hepatol. 10: 651-656. [Medline] [CrossRef]
9. Day, C.P. 2002. NASH-related liver failure: one hit too many? Am. J. Gastroenterol. 97: 1872-1874. [Medline] [CrossRef]
10. Day, C.P. and James, O.F. 1998. Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845. [Medline] [Cross-Ref]
11. Hebert, J.M., Rosenquist, T., Gotz, J., and Martin, G.R. 1994. FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations. Cell 78: 1017-1025. [Medline] [CrossRef]
12. Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W., Ferrell, L.D., Liu, Y.C., Torbenson, M.S., Unalp-Arida, A., Yeh, M., McCullough, A.J., Sanyal, A.J., and Nonalcoholic Steatohepatitis Clinical Research, N. 2005. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321. [Medline] [CrossRef]
13. Liu, C., Li, H., Qi, Q., Lu, L., Gan, W., Loos, R.J., and Lin, X. 2011. Common variants in or near FGF5, CYP17A1 and MTHFR genes are associated with blood pressure and hypertension in Chinese Hans. J. Hypertens. 29: 70-75. [Medline] [CrossRef]
14. McKeehan, W.L., Wang, F., and Kan, M. 1998. The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog. Nucleic. Acid Res. Mol. Biol. 59: 135-176. [Medline] [CrossRef]
15. Mizuno, S., Iijima, S., Okano, T., Kajiwara, N., Kunita, S., Sugiyama, F., and Yagami, K. 2011. Retrotransposon-mediated Fgf5(go-Utr) mutant mice with long pelage hair. Exp. Anim. 60: 161-167. [Medline] [CrossRef]
16. Nakagami, H., Kiomy Osako, M., Nakagami, F., Shimosato, T., Minobe, N., Moritani, T., Shimamura, M., Miyake, T., Shimizu, H., Takeya, Y., and Morishita, R. 2010. Prevention and regression of non-alcoholic steatohepatitis (NASH) in a rat model by metabosartan, telmisartan. Int. J. Mol. Med. 26: 477-481. [Medline]
17. Newton-Cheh, C., Johnson, T., Gateva, V., Tobin, M.D., Bochud, M., Coin, L., Najjar, S.S., Zhao, J.H., Heath, S.C., Eyheramendy, S., Papadakis, K., Voight, B.F., Scott, L.J., Zhang, F., Farrall, M., Tanaka, T., Wallace, C., Chambers, J.C., Khaw, K.T., Nilsson, P., van der Harst, P., Polidoro, S., Grobbee, D.E., Onland-Moret, N.C., Bots, M.L., Wain, L.V., Elliott, K.S., Teumer, A., Luan, J., Lucas, G., Kuusisto, J., Burton, P.R., Hadley, D., McArdle, W.L., Brown, M., Dominiczak, A., Newhouse, S.J., Samani, N.J., Webster, J., Zeggini, E., Beckmann, J.S., Bergmann, S., Lim, N., Song, K., Vollenweider, P., Waeber, G., Waterworth, D.M., Yuan, X., Groop, L., Orho-Melander, M., Allione, A., Di Gregorio, A., Guarrera, S., Panico, S., Ricceri, F., Romanazzi, V., Sacerdote, C., Vineis, P., Barroso, I., Sandhu, M.S., Luben, R.N., Crawford, G.J., Jousilahti, P., Perola, M., Boehnke, M., Bonnycastle, L.L., Collins, F.S., Jackson, A.U., Mohlke, K.L., Stringham, H.M., Valle, T.T., Willer, C.J., Bergman, R.N., Morken, M.A., Doring, A., Gieger, C., Illig, T., Meitinger, T., Org, E., Pfeufer, A., Wichmann, H.E., Kathiresan, S., Marrugat, J., O'Donnell, C.J., Schwartz, S.M., Siscovick, D.S., Subirana, I., Freimer, N.B., Hartikainen, A.L., McCarthy, M.I., O'Reilly, P.F., Peltonen, L., Pouta, A., de Jong, P.E., Snieder, H., van Gilst, W.H., Clarke, R., Goel, A., Hamsten, A., Peden, J.F., Seedorf, U., Syvanen, A.C., Tognoni, G., Lakatta, E.G., Sanna, S., Scheet, P., Schlessinger, D., Scuteri, A., Dorr, M., Ernst, F., Felix, S.B., Homuth, G., Lorbeer, R., Reffelmann, T., Rettig, R., Volker, U., Galan, P., Gut, I.G., Hercberg, S., Lathrop, G.M., Zelenika, D., Deloukas, P., Soranzo, N., Williams, F.M., Zhai, G., Salomaa, V., Laakso, M., Elosua, R., Forouhi, N.G., Volzke, H., Uiterwaal, C.S., van der Schouw, Y.T., Numans, M.E., Matullo, G., Navis, G., Berglund, G., Bingham, S.A., Kooner, J.S., Connell, J.M., Bandinelli, S., Ferrucci, L., Watkins, H., Spector, T.D., Tuomilehto, J., Altshuler, D., Strachan, D.P., Laan, M., Meneton, P., Wareham, N.J., Uda, M., Jarvelin, M.R., Mooser, V., Melander, O., Loos, R.J., Elliott, P., Abecasis, G.R., Caulfield, M., and Munroe, P.B. 2009. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. 41: 666-676. [Medline] [CrossRef]
18. Sundberg, J.P., Rourk, M.H., Boggess, D., Hogan, M.E., Sundberg, B.A., and Bertolino, A.P. 1997. Angora mouse mutation: altered hair cycle, follicular dystrophy, phenotypic maintenance of skin grafts, and changes in keratin expression. Vet. Pathol. 34: 171-179. [Medline] [CrossRef]
19. Suzuki, S., Kato, T., Takimoto, H., Masui, S., Oshima, H., Ozawa, K., Suzuki, S., and Imamura, T. 1998. Localization of rat FGF-5 protein in skin macrophage-like cells and FGF-5S protein in hair follicle: possible involvement of two Fgf-5 gene products in hair growth cycle regulation. J. Invest. Dermatol. 111: 963-972. [Medline] [CrossRef]
20. Suzuki, S., Ota, Y., Ozawa, K., and Imamura, T. 2000. Dual-mode regulation of hair growth cycle by two Fgf-5 gene products. J. Invest. Dermatol. 114: 456-463. [Medline] [CrossRef]
21. Taniguchi, F., Harada, T., Sakamoto, Y., Yamauchi, N., Yoshida, S., Iwabe, T., and Terakawa, N. 2003. Activation of mitogen-activated protein kinase pathway by keratinocyte growth factor or fibroblast growth factor-10 promotes cell proliferation in human endometrial carcinoma cells. J. Clin. Endocrinol. Metab. 88: 773-780. [Medline] [CrossRef]
22. Teli, M.R., James, O.F., Burt, A.D., Bennett, M.K., and Day, C.P. 1995. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22: 1714-1719. [Medline] [CrossRef]
23. Xi, B., Shen, Y., Reilly, K.H., Wang, X., and Mi, J. 2013. Recapitulation of four hypertension susceptibility genes (CSK, CYP17A1, MTHFR, and FGF5) in East Asians. Metabolism 62: 196-203. [Medline] [CrossRef]
24. Zhan, X., Bates, B., Hu, X.G., and Goldfarb, M. 1988. The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors. Mol. Cell Biol. 8: 3487-3495. [Medline]